Featured Service
Fast, Reliable Gene‑to‑Clinic Development
Bring your biologic program to life with an end‑to‑end CRADS platform
View service
Need a quote or have a question?
Send us the details — our scientists will review and respond.
Capabilities by industry
Drug Discovery & Development
End-to-end testing across the drug-development lifecycle — discovery, preclinical, clinical, cGMP analytical and biologics. The practice that built Vimta, audited by every major submission market we file in.
Food & Personal Care
Nutritional analysis, pesticide residue, contaminant testing and FMCG product safety — covering FSSAI, EU MRLs, and every major export market.
Electricals & Electronics
EMI/EMC, safety, environmental and certification testing across seven product domains — including avionics and defence electronics.
Focus Areas
Environment, Health & Safety
Ambient, stack, water, soil and waste analytics for EIAs, post-project monitoring and CPCB-mandated submissions.
Crop Care & Specialty Chemicals
Contract research and regulatory studies for agrochemicals and specialty chemicals — registration, efficacy and residue work under GLP.
Focus Areas
Choose an industry
Accredited by
- NABL
- ISO 17025
- GLP
- GMP
- OECD
- WHO-GMP
- FSSAI
- DSIR
- BIS
Featured Services
-
Analytical Services for Preclinical
GLP-compliant analytical and bioanalytical support for preclinical studies — dose analysis, method development and validation, and sample testing, with fast tur
Explore service -
Test to regulatory standards and beyond. Iterative pre-compliance testing to fix design issues early, plus full compliance testing with verified reports.
Explore service -
Safety and Performance Testing
Safety and performance testing across LED, UPS, medical, IT and fan categories to IS, IEC and EN standards. Verified reports for certification and BEE labelling
Explore service -
Drug substance and excipient release testing to the latest pharmacopoeial standards and validated methods, with early detection of low-level impurities.
Explore service
-
End-to-end BA/BE studies proving test-vs-reference comparability. 1700+ studies, LC-MS/MS to picogram levels, CDISC submissions, global inspection-ready.
Explore service -
Early Drug Discovery & Development
Fast-track lead identification with VIMTA's early drug discovery services — integrated in vitro/in vivo efficacy, PK-PD, and safety models for confident decisio
Explore service -
Regulatory-ready general toxicology studies — GLP-compliant MTD, dose-range, and 28-day repeat-dose testing in rodents & non-rodents, from Beagle dogs to mini p
Explore service -
Toxicological Risk Assessments
Toxicological risk assessment for chemical constituents and packaging materials — systemic, genotoxic, carcinogenic and reproductive risk, to regulatory standar
Explore service
-
BIS-approved testing for CRS registration. Get products notified under MeitY and MNRE tested for Standard Mark licensing and faster market access in India.
Explore service -
CE Marking Certification and Testing
CE marking support across LVD, RED, EMC and other EU directives. Test your products for European safety, health and environmental requirements with Vimta Labs.
Explore service -
TEC-approved testing for MTCTE certification of telecom equipment. Get products tested against Essential Requirements under DoT's mandatory scheme.
Explore service -
Government-approved AGMARK grading services for agricultural products. Get commodities graded to prescribed standards under the Grading and Marking Act.
Explore service
Find your service
Explore Vimta's service catalogue
About Vimta Labs
A Pioneer in Scientific Excellence Since 1984
Founded in Hyderabad in 1984, Vimta Labs has grown into one of India's foremost Contract Research & Testing Organization — serving 30,000+ clients across pharma, food, environment, and electronics from state-of-the-art facilities spanning 6 lakh sq ft.
Sq. Ft. of Ultra-Modern Lab Space
Customers
External Audits Annually
Countries Served Globally
Insights Hub
Thinking That Drives Progress
Research, events, case studies and careers from Vimta's scientists and regulatory experts.
White Papers
Opportunities for Nonclinical Safety Evaluation of Therapeutic Monoclonal Antibodies PDF, opens in a new tab
Designing nonclinical safety studies for monoclonal antibodies, discovery through approval.
White Papers
Extended One-Generation Reproductive Toxicity Study of Thiamethoxam Technical in Rats PDF, opens in a new tab
Extended one-generation reproductive toxicity of thiamethoxam technical assessed in rats across multiple generations and endpoints.
White Papers
Developmental Neurotoxicity of Thiamethoxam in Wistar Rats. PDF, opens in a new tab
Developmental neurotoxicity of thiamethoxam, a neonicotinoid insecticide, evaluated in Wistar rats per OECD guideline 426.
Brochures
Electrical & Electronics Product Qualification PDF, opens in a new tab
Electrical & Electronics Product Qualification
Brochures
Partnering in Discovery & Development of Biologics & Peptides PDF, opens in a new tab
Partnering in Discovery & Development of Biologics & Peptides
FAQ
Frequently Asked Questions
Quick answers to the questions we hear most often from our clients and partners.
Vimta provides end-to-end contract testing and research across five sectors: pharma & biopharma (bioanalytical, clinical, CMC, stability, drug discovery support), food & personal care, electricals & electronics (EMI/EMC, safety, performance), environment health & safety, and crop care & specialty chemicals. Services span method development, regulatory testing, GLP/GMP studies, and product certification — all delivered from our NABL- and GLP-accredited facilities in Hyderabad.
Our labs operate under NABL (ISO/IEC 17025), GLP (OECD principles), USFDA inspections, WHO-GMP, CDSCO, FSSAI, BIS, and DSIR, among 30+ international accreditations. Reports issued by Vimta are accepted by regulators in the US, EU, Japan, and across Asia-Pacific, so sponsors can file submissions globally without redundant re-testing.
Share your study outline or sample details through our Contact form, email enquiry@vimta.com, or call the Hyderabad facility directly. Our project management team typically reaches out within one business day with a scoped quote, turnaround estimate, and shipping instructions. For regulated-study sponsors we also sign CDAs upfront.
Turnaround depends on matrix, method status, and regulatory scope. Routine analytical testing is usually 5–10 business days; validated bioanalytical sample analysis runs on scheduled batches with study-specific timelines; GLP toxicology and stability studies follow protocol-defined durations. Every quote includes a concrete timeline and milestone plan so you can align internal submissions.
Yes. Every engagement starts with a mutual CDA, followed by a study-specific contract covering data ownership, retention, and audit rights. Study data is held in 21 CFR Part 11–compliant systems with role-based access, and our QA unit archives raw data under GLP/GCP record-keeping rules. Sponsor representatives can audit studies on-site or remotely by prior arrangement.
Get in touch
Let's discuss your testing needs
Whether you need a single test or a full-scale contract research programme, our team is ready to scope the right solution for you.
Registered Office & Central Lab
Address: 142, IDA,Phase II, Cherlapally
Hyderabad – 500 051 India.
Life Sciences Campus
#5, Neovantage Innovation ParksGenome Valley, Shameerpet
Hyderabad – 500101, Telangana, India.
Send us an enquiry
Tell us about your testing or research needs and we'll scope the right solution.
Careers at Vimta
Be Part of a High-Performance Organization
Join 1,500+ scientists, engineers, and analysts solving real problems for pharma, food, and electronics companies across the world.